Compare · CL vs WALD
CL vs WALD
Side-by-side comparison of Colgate-Palmolive Company (CL) and Waldencast plc (WALD): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both CL and WALD operate in Package Goods/Cosmetics (Consumer Discretionary), so they compete in similar markets.
- CL is the larger of the two at $72.81B, about 416.3x WALD ($174.9M).
- WALD has been more active in the news (4 items in the past 4 weeks vs 3 for CL).
- CL has more recent analyst coverage (25 ratings vs 11 for WALD).
- Company
- Colgate-Palmolive Company
- Waldencast plc
- Price
- $92.03+0.77%
- $1.37+0.00%
- Market cap
- $72.81B
- $174.9M
- 1M return
- -
- -18.45%
- 1Y return
- -
- -13.56%
- Industry
- Package Goods/Cosmetics
- Package Goods/Cosmetics
- Exchange
- NYSE
- NASDAQ
- IPO
- 2021
- News (4w)
- 3
- 4
- Recent ratings
- 25
- 11
Colgate-Palmolive Company
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. The company operates through two segments, Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment's products include toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other similar items. This segment markets and sells its products to various retailers, wholesalers, and distributors. The Pet Nutrition segment offers pet nutrition products for everyday nutritional needs; and a range of therapeutic products to manage disease conditions in dogs and cats. This segment markets and sells its products through pet supply retailers, veterinarians, and eCommerce retailers. Its principal global and regional trademarks include Colgate, Palmolive, elmex, hello, meridol, Sorriso, Tom's of Maine, EltaMD, Filorga, Irish Spring, Lady Speed Stick, PCA Skin, Protex, Sanex, Softsoap, Speed Stick, Ajax, Axion, Fabuloso, Murphy, Soupline, and Suavitel, as well as Hill's Science Diet and Hill's Prescription Diet. Colgate-Palmolive Company was founded in 1806 and is headquartered in New York, New York.
Waldencast plc
Waldencast Acquisition Corp. focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. It intends to identify businesses in the beauty, personal care, and wellness sectors. The company was incorporated in 2020 and is based in White Plains, New York.
Latest CL
- COO, CD, EMEA, APac, Skin Tsourapas Panagiotis sold $920,477 worth of shares (10,000 units at $92.05) (SEC Form 4)
- Director Cahill John T exercised 4,170 shares at a strike of $71.56 and sold $389,358 worth of shares (4,170 units at $93.37) (SEC Form 4)
- Chairman, President & CEO Wallace Noel R. sold $29,698,617 worth of shares (322,042 units at $92.22) and exercised 322,042 shares at a strike of $72.29 (SEC Form 4) to satisfy withholding obligation
- SEC Form 10-Q filed by Colgate-Palmolive Company
- Colgate-Palmolive Company filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- Colgate Announces 2nd Quarter 2026 Results
- Colgate-Palmolive Webcasts 2026 Second Quarter Earnings Conference Call July 31, 2026 – 8:30 a.m. ET
- Director Bilbrey John P was granted 265 shares, increasing direct ownership by 0.66% to 40,229 units (SEC Form 4)
- Director Norrington Lorrie M was granted 293 shares, increasing direct ownership by 0.69% to 42,769 units (SEC Form 4)
- Director Newman Brian was granted 209 shares, increasing direct ownership by 3% to 7,831 units (SEC Form 4)
Latest WALD
- SEC Form 4 filed by Chief Executive Officer Brousset Michel
- SEC Form 4 filed by Chief Growth Officer Sebti Hind
- Chief Financial Officer Manfredi Manuel converted options into 79,289 units of Class A Ordinary Shares, increasing direct ownership by 200% to 118,933 units (SEC Form 4)
- SEC Form 6-K filed by Waldencast plc
- SEC Form 6-K filed by Waldencast plc
- SEC Form 6-K filed by Waldencast plc
- Waldencast Announces Completion of the Sale of Obagi Medical to Bridgepoint
- SEC Form 6-K filed by Waldencast plc
- SEC Form 6-K filed by Waldencast plc
- Obagi Medical Announces FDA Approval of Obagi® saypha® ChIQ™ Injectable Hyaluronic Acid Gel